NDC 70518-4404-00 - ALLOPURINOL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4404
- Requested NDC
- 70518-4404-00
- Package NDCs from labels
- 70518-4404-0, 70518-4404-1, 70518-4404-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-02-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALLOPURINOL - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-02-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4404-0 | ALLOPURINOL | 30 in 1 BLISTER PACK | TABLET | 30 | 2 | |
| 70518-4404-1 | ALLOPURINOL | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALLOPURINOL | ALLOPURINOL | A-S Medication Solutions | 78978de2-1842-4570-9d11-67f13cc37ad5 | 2025-10-14 | Warnings, Adverse reactions | ANDA217748 197319 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | A-S Medication Solutions | 5955ca3f-9383-4025-ac58-90394716493a | 2025-10-14 | Warnings, Adverse reactions | ANDA217748 197319 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Bryant Ranch Prepack | e453a5e0-44c3-4eb5-a8d0-7c02157d2f8c | 2025-10-02 | Warnings, Adverse reactions | ANDA217748 197319 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Preferred Pharmaceuticals Inc. | d83fec65-396a-40bd-8ee8-828d8930ea41 | 2025-09-22 | Warnings, Adverse reactions | ANDA217748 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | 3f0134bf-b62f-1077-e063-6394a90a60b0 | 2025-09-17 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Indoco Remedies Limited | 48a9a6c3-4604-421e-a323-1133888aaf76 | 2025-08-21 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Mylan Institutional Inc. | 994b3117-b83e-44d9-910c-1c3a26ef838e | 2025-07-18 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals,Inc. | 3845c310-099b-8e11-e063-6394a90abd2f | 2025-06-23 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Zydus Lifesciences Limited | 9232f484-a5f6-4c63-b7f4-b510d2827159 | 2025-06-18 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Advanced Rx of Tennessee, LLC | 36c1c908-1eed-ed2a-e063-6294a90a16f9 | 2025-05-29 | Warnings, Adverse reactions | ANDA217748 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | American Health Packaging | f6f7642b-5046-47d6-b259-0c9f8aed3b34 | 2025-05-14 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 09d34fab-250c-496a-93f5-c8d9f52a2276 | 2025-04-23 | Warnings, Adverse reactions | ANDA217748 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Zydus Pharmaceuticals (USA) Inc. | 8b926e62-3a9c-424a-833a-8169e55a1f15 | 2025-04-07 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals, Inc. | 2f27f578-f965-04c9-e063-6394a90a1ae2 | 2025-02-27 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Coupler LLC | 2d6ce57f-a9df-319e-e063-6394a90ac93f | 2025-02-05 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals,Inc. | faf55184-6962-d49f-e053-6394a90a152e | 2025-02-04 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 5a1bfae2-116f-4ef9-bb7b-3b69ac74df03 | 2025-01-30 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Redpharm Drug | 0a22fa72-c363-4e96-e063-6394a90a48aa | 2025-01-23 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Harman Finochem Limited | 0780dc78-d287-d5db-e063-6294a90aa1dd | 2025-01-09 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 7f9ad8db-ae68-4a0c-b858-1e727bc98130 | 2025-01-03 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.